Correction of Morphofunctional Disorders of the Cardiovascular System With Asialized Erythropoietin and Arginase II Selective Inhibitors KUD 974 and KUD 259 in Experimental Preeclampsia

Research Results in Pharmacology
doi 10.3897/rrpharmacology.6.50851
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pensoft Publishers

Related search

Correction of Morphofunctional Disorders With Asialoerythropoietin and Selective Inhibitor of Arginase II KUD975 in Cases of Ischemic Kidney Damage in the Experiment

Research Results in Pharmacology
2018English

Correction of Morphofunctional Disturbances Arising When Modelling Preeclampsia With Resveratrol and Nicorandil

Research Results in Pharmacology
2018English

Placental Expression of Erythropoietin in Preeclampsia

Rossiiskii vestnik akushera-ginekologa
2015English

Identification of Helminth Parasites in Dairy Cow Through Feces Examination in the Koperasi Unit Desa (KUD) Karangploso Malang

2018English

Deficient Arginase II Expression Without Alteration in Arginase I Expression Attenuated Experimental Autoimmune Encephalomyelitis in Mice

Immunology
AllergyImmunology
2018English

Comorbid Cardiovascular System Disorders in Patients With Cryoglobulinaemia

Kazan medical journal
2016English

Evidence for Increased Methylglyoxal in the Vasculature of Women With Preeclampsia: Role in Upregulation of LOX-1 and Arginase

Hypertension
Internal Medicine
2009English

Review of the Methodological Manual “Methodology for Determining Whether a Blockchain Token Corresponds to a Digital Asset”, Author Aleksandr Kud

International Journal of Education and Science
2019English

Expression of Arginase II in Prostate Cancer

International Journal of Oncology
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy